These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14659739)

  • 21. Generation of antibody molecules through antibody engineering.
    Kipriyanov SM
    Methods Mol Biol; 2003; 207():3-25. PubMed ID: 12412465
    [No Abstract]   [Full Text] [Related]  

  • 22. Thermostable llama single domain antibodies for detection of botulinum A neurotoxin complex.
    Goldman ER; Anderson GP; Conway J; Sherwood LJ; Fech M; Vo B; Liu JL; Hayhurst A
    Anal Chem; 2008 Nov; 80(22):8583-91. PubMed ID: 18947189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance evaluation of phage-displayed synthetic human single-domain antibody libraries: A retrospective analysis.
    Henry KA; Tanha J
    J Immunol Methods; 2018 May; 456():81-86. PubMed ID: 29462605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Llama single domain antibodies as a tool for molecular mimicry.
    Zarebski LM; Urrutia M; Goldbaum FA
    J Mol Biol; 2005 Jun; 349(4):814-24. PubMed ID: 15890359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiplexed fluid array screening of phage displayed anti-ricin single domain antibodies for rapid assessment of specificity.
    Anderson GP; Matney R; Liu JL; Hayhurst A; Goldman ER
    Biotechniques; 2007 Dec; 43(6):806-11. PubMed ID: 18251258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COMBODY: one-domain antibody multimer with improved avidity.
    Zhu X; Wang L; Liu R; Flutter B; Li S; Ding J; Tao H; Liu C; Sun M; Gao B
    Immunol Cell Biol; 2010 Aug; 88(6):667-75. PubMed ID: 20212511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria.
    Benhar I; Azriel R; Nahary L; Shaky S; Berdichevsky Y; Tamarkin A; Wels W
    J Mol Biol; 2000 Aug; 301(4):893-904. PubMed ID: 10966794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library.
    Liu JL; Anderson GP; Delehanty JB; Baumann R; Hayhurst A; Goldman ER
    Mol Immunol; 2007 Mar; 44(7):1775-83. PubMed ID: 17007931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin type III domain based monobody with high avidity.
    Duan J; Wu J; Valencia CA; Liu R
    Biochemistry; 2007 Nov; 46(44):12656-64. PubMed ID: 17929945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability-Diversity Tradeoffs Impose Fundamental Constraints on Selection of Synthetic Human V
    Henry KA; Kim DY; Kandalaft H; Lowden MJ; Yang Q; Schrag JD; Hussack G; MacKenzie CR; Tanha J
    Front Immunol; 2017; 8():1759. PubMed ID: 29375542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system.
    Deng XK; Nesbit LA; Morrow KJ
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):587-95. PubMed ID: 12853390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An improved helper phage system for efficient isolation of specific antibody molecules in phage display.
    Baek H; Suk KH; Kim YH; Cha S
    Nucleic Acids Res; 2002 Mar; 30(5):e18. PubMed ID: 11861923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of single-domain antibody multimers with three different self-associating peptides.
    Wang L; Liu X; Zhu X; Wang L; Wang W; Liu C; Cui H; Sun M; Gao B
    Protein Eng Des Sel; 2013 Jun; 26(6):417-23. PubMed ID: 23538432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimerization domains for antibody phage display and antibody production.
    Thie H; Binius S; Schirrmann T; Hust M; Dübel S
    N Biotechnol; 2009 Dec; 26(6):314-21. PubMed ID: 19631299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody therapeutics, antibody engineering, and the merits of protein stability.
    Demarest SJ; Glaser SM
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterodimeric CD3epsilongamma extracellular domain fragments: production, purification and structural analysis.
    Kim KS; Sun ZY; Wagner G; Reinherz EL
    J Mol Biol; 2000 Sep; 302(4):899-916. PubMed ID: 10993731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection and characterization of single domain antibodies against human CD20.
    Liu JL; Zabetakis D; Goldman ER; Anderson GP
    Mol Immunol; 2016 Oct; 78():146-154. PubMed ID: 27639717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs.
    Mössner E; Koch H; Plückthun A
    J Mol Biol; 2001 Apr; 308(2):115-22. PubMed ID: 11327756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody Fab display and selection through fusion to the pIX coat protein of filamentous phage.
    Tornetta M; Baker S; Whitaker B; Lu J; Chen Q; Pisors E; Shi L; Luo J; Sweet R; Tsui P
    J Immunol Methods; 2010 Aug; 360(1-2):39-46. PubMed ID: 20600082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alternative scaffold proteins].
    Petrovskaia LE; Shingarova LN; Dolgikh DA; Kirpichnikov MP
    Bioorg Khim; 2011; 37(5):581-91. PubMed ID: 22332353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.